AGILE THERAPEUTICS INC's ticker is AGRX and the CUSIP is 00847L100. A total of 51 filers reported holding AGILE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $4,664,000 | -4.7% | 1,814,949 | -0.3% | 5.06% | -15.0% |
Q4 2017 | $4,896,000 | -39.7% | 1,820,012 | 0.0% | 5.95% | -28.0% |
Q3 2017 | $8,117,000 | +33.3% | 1,820,012 | +12.1% | 8.26% | -13.0% |
Q2 2017 | $6,088,000 | +17.0% | 1,623,567 | 0.0% | 9.50% | -36.1% |
Q1 2017 | $5,204,000 | -57.0% | 1,623,567 | -23.5% | 14.86% | -64.0% |
Q4 2016 | $12,104,000 | -2.3% | 2,123,567 | +19.7% | 41.30% | -25.5% |
Q3 2016 | $12,385,000 | +3.0% | 1,774,319 | +12.3% | 55.46% | +308.7% |
Q2 2016 | $12,028,000 | +35.6% | 1,580,491 | +10.6% | 13.57% | +10.8% |
Q1 2016 | $8,873,000 | +3843.6% | 1,428,871 | +6103.0% | 12.24% | +1197.1% |
Q4 2015 | $225,000 | +45.2% | 23,035 | 0.0% | 0.94% | +351.7% |
Q3 2015 | $155,000 | +2.6% | 23,035 | +31.2% | 0.21% | +30.6% |
Q2 2015 | $151,000 | -39.1% | 17,559 | -34.3% | 0.16% | -45.9% |
Q1 2015 | $248,000 | +36.3% | 26,736 | -9.8% | 0.30% | +41.6% |
Q4 2014 | $182,000 | -9.0% | 29,645 | +8.1% | 0.21% | +1.5% |
Q3 2014 | $200,000 | -7.8% | 27,415 | +10.1% | 0.21% | +23.4% |
Q2 2014 | $217,000 | – | 24,911 | – | 0.17% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 31,839,850 | $42,348,000 | 0.28% |
NEEDHAM INVESTMENT MANAGEMENT LLC | 735,000 | $978,000 | 0.14% |
INVESTOR AB | 3,510,189 | $4,669,000 | 0.14% |
Tibra Equities Europe Ltd | 241,100 | $321,000 | 0.10% |
FIRST MIDWEST BANK TRUST DIVISION | 349,158 | $464,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 372,543 | $495,000 | 0.06% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 110,000 | $146,000 | 0.04% |
Kalos Management, Inc. | 19,250 | $24,000 | 0.01% |
Summit Global Investments | 110,100 | $146,000 | 0.01% |
Founders Capital Management | 10,000 | $13,000 | 0.01% |